Sandbox: jss: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
{{familytree | | | B01 | | | | | | | | | | | | | B02 | | |B01=GFR <15ml/min/1.73m2|B02=GFR>15ml/min/1.73m2}} | {{familytree | | | B01 | | | | | | | | | | | | | B02 | | |B01=GFR <15ml/min/1.73m2|B02=GFR>15ml/min/1.73m2}} | ||
{{familytree | | | |!| | | | | | | | | | | | | | |!| | | | }} | {{familytree | | | |!| | | | | | | | | | | | | | |!| | | | }} | ||
{{familytree | | | C01 | | | | | | | | | | | | | | {{familytree | | | C01 | | | | | | | | | | | | | |!| |C01=Measure urinary potassium|C02=Measure Aldosterone}} | ||
{{familytree | |,|-|^|-|.| | | | | | | | | | | | {{familytree | |,|-|^|-|.| | | | | | | | |,|-|-|-|+|-|-|-|.| | }} | ||
{{familytree | D01 | | D02 | | | | | | | | | | {{familytree | |!| | | |!| | | | | | | | |!| | | |!| | | |!| | }} | ||
{{familytree | |!| | | |!| | | | | | | | | | | | {{familytree | D01 | | D02 | | | | | | | D03| | |D04 | | D05| |D01=Urine potassium <20meq/L|D02=urine potassium >125meq/L|D03=Aldosterone low|D04=Aldosterone normal\high}} | ||
{{familytree | E01 | | E02 | | | | | | | | | | {{familytree | |!| | | |!| | | | | | | | |!| | | |!| | | | }} | ||
{{familytree | E01 | | E02 | | | | | | | E03 | | E04 | | | |E01=*Acute renal failure<br>Chronic renal failure<br>Heart failure<br>Volume depletion<br>Tissue breakdown<br>*Blood transfusion|E02=Supplemental potassium|E03=Measure renin|E04=Pseudohypoaldostrenism type 1 and type 2<br>Aldosterone receptor antagonist<br>Amiloride<br>Sprironolactone<br>Type 1 RTA }} | |||
{{familytree | | | | | |!| | | | | | | | | | |!| | | |!| | | | }} | {{familytree | | | | | |!| | | | | | | | | | |!| | | |!| | | | }} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | | | |!| | }} | ||
{{familytree | | | |,|-|^|-|.| | | | | | |,|-|^|-|.| |!| | }} | {{familytree | | | |,|-|^|-|.| | | | | | |,|-|^|-|.| |!| | }} | ||
{{familytree | | | G01 | | G02 | | | | | G03 | | G04 |!| | |G01=G01|G02=G02|G03=Renin low|G04=Renin normal/high}} | {{familytree | | | G01 | | G02 | | | | | G03 | | | | G04 |!| | |G01=G01|G02=G02|G03=Renin low|G04=Renin normal/high}} | ||
{{familytree | | | |!| | | |!| | | | | | |!| | | | | {{familytree | | | |!| | | |!| | | | | | |!| | | |,|-|^|-|v|-|-|.|}} | ||
{{familytree | | | H01 | | H02 | | | | | H03 | | H04 | | | |H01=H01|H02=H02|H03=Hyporenimic Hypoaldosteronism|H04=Primary hypoaldosteronism<br>Congenital adrenal hyperplasia<br>Secondary hypoaldosteronism<br>Drugs}} | {{familytree | | | H01 | | H02 | | | | | H03 | | H04 | | H05 | | H06 |H01=H01|H02=H02|H03=Hyporenimic Hypoaldosteronism|H04=Primary hypoaldosteronism<br>Congenital adrenal hyperplasia<br>Secondary hypoaldosteronism<br>Drugs|H05=High serum osmolarity<br>Diabteic Ketoacidosis|H06=Metabloic acidosis}} | ||
{{familytree | | | |!| | | | | | | | | | |!| | | |!| | | | | }} | {{familytree | | | |!| | | | | | | | | | |!| | | |!| | | | | }} | ||
{{familytree | | | I01 | | | | | | | | | I02 | | I03 | | | |I01=I01|I02=Interstitial nephritis<br>Obstructive uropathy<br>ACE inhibitors<Angiotensin 2 receptor antagonists |I03=}} | {{familytree | | | I01 | | | | | | | | | I02 | | I03 | | | |I01=I01|I02=Interstitial nephritis<br>Obstructive uropathy<br>ACE inhibitors<Angiotensin 2 receptor antagonists |I03=}} | ||
Revision as of 20:17, 6 July 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
| Serum Potassium >5.1meq/L | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Measure GFR | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GFR <15ml/min/1.73m2 | GFR>15ml/min/1.73m2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Measure urinary potassium | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Urine potassium <20meq/L | urine potassium >125meq/L | Aldosterone low | Aldosterone normal\high | {{{ D05}}} | |||||||||||||||||||||||||||||||||||||||||||||||||||
| *Acute renal failure Chronic renal failure Heart failure Volume depletion Tissue breakdown *Blood transfusion | Supplemental potassium | Measure renin | Pseudohypoaldostrenism type 1 and type 2 Aldosterone receptor antagonist Amiloride Sprironolactone Type 1 RTA | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| G01 | G02 | Renin low | Renin normal/high | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| H01 | H02 | Hyporenimic Hypoaldosteronism | Primary hypoaldosteronism Congenital adrenal hyperplasia Secondary hypoaldosteronism Drugs | High serum osmolarity Diabteic Ketoacidosis | Metabloic acidosis | ||||||||||||||||||||||||||||||||||||||||||||||||||
| I01 | Interstitial nephritis Obstructive uropathy ACE inhibitors<Angiotensin 2 receptor antagonists | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J01 | J02 | J03 | J04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| K01 | K02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||